Примери за използване на Generalisation in adults на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Partial onset seizures with or without generalisation in adults, adolescents, children and infants from one month of age.
Is used to treat a certain form of epilepsy(partial seizures with or without secondary generalisation) in adults.
Partial onset seizures with or without generalisation in adults, adolescents, children and infants from one month of age.
Adjunctive therapy in the treatment of partial seizures,with or without secondary generalisation in adults.
This medicine is used to treat a certain form of epilepsy(partial seizures with or without secondary generalisation) in adults.
Adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents, children and infants from 1 month of age with epilepsy.
Epilepsy: Lyrica is used to treat a certain form of epilepsy(partial seizures with or without secondary generalisation) in adults.
As an add-on to other antiepileptic medicines to treat:partial onset seizures with or without generalisation in adults, adolescents and children from 4 years of age myoclonic seizures(short, shock-like jerks of a muscle or group of muscles) in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.
Monotherapy in the treatment of partial-onset seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;
Keppra is indicated as adjunctive therapy• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.•in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
Adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.
Levetiracetam SUN is indicated as adjunctive therapy- in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy- in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy- in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
Zonegran is indicated as: monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;
Monotherapy in the treatment of partial seizures,with or without secondary generalisation, in adults with newly diagnosed epilepsy(see section 5.1);
The Committee for Medicinal Products for Human Use(CHMP)decided that Exalief's benefits are greater than its risks for the treatment of partial-onset seizures with or without secondary generalisation in adults who are also taking other anti-epilepsy medicines.
Adjunctive therapy in the treatment of partial seizures,with or without secondary generalisation, in adults, adolescents, and children aged 6 years and above.
Monotherapy in the treatment of partial seizures,with or without secondary generalisation, in adults with newly diagnosed epilepsy(see section 5.1);
Briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
Matever is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Levetiracetam Hospira is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Levetiracetam Actavis is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents, children and infants from 1 month of age with epilepsy.
Vimpat is indicated as monotherapy andadjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.